News

Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...
Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast tissue cell growth in a Northwestern University study.
More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two Phase 3 trials for its non-hormonal drug candidate, elinzanetant, meant to treat hot flashes.
Even menopause is different, with Black women experiencing more hot flashes and night sweats than White women. Although a two-decade study of women of different races and ethnicities has provided ...